Cardioprotective effects of timosaponin B-II isolated from Anemarrhena rhizome in a zebrafish model / Yan-Mei Zhong, Chu-Qin Yu, Meng-Jiao Du, Jian-Ping Chen, Bo-Wen Lian, Wen-Jie Mei, Jia-Xian Yu, Li-Shi Chen, Shan-Bin Deng
Abstract Timosaponin B-II (TB-II; (25S)-26-(β-D-glucopyranosyloxy)-3β-[(2-O-β-D-glucopyranosyl-β-D-galactopyranosyl) oxy]-5β-furostan-22-ol is extracted from Anemarrhena. Its anti-inflammation, anti-oxidation, and anti-asthma properties have been widely explored. However, its effect on the heart has not been reported. In this study, we used zebrafish as a research model to determine the effects of TB-II on the heart and its toxic and anti-inflammatory effects. To explore the cause of cardioprotective effects of TB-II, we used transgenic zebrafish with macrophages and neutrophils labeled with fluorescent protein. We found for the first time that TB-II had a protective effect on the zebrafish heart. It did not affect the survival and hatching rates of zebrafish embryos, indicating its low toxicity. Results showed that TB-II may have cardioprotective effects, which might be related to its anti-inflammatory effects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
---|---|
Enthalten in: |
Die Pharmazie |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhong, Yan-Mei [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Umfang: |
1 Online-Ressource (4 p) |
---|
doi: |
10.1691/ph.2020.9869 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011218673 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011218673 | ||
003 | DE-627 | ||
005 | 20231127160107.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230714s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1691/ph.2020.9869 |2 doi | |
035 | |a (DE-627)KFL011218673 | ||
035 | |a (KFL)prod_EACS_10.1691/ph.2020.9869 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Zhong, Yan-Mei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardioprotective effects of timosaponin B-II isolated from Anemarrhena rhizome in a zebrafish model |c Yan-Mei Zhong, Chu-Qin Yu, Meng-Jiao Du, Jian-Ping Chen, Bo-Wen Lian, Wen-Jie Mei, Jia-Xian Yu, Li-Shi Chen, Shan-Bin Deng |
264 | 1 | |c 2020 | |
300 | |a 1 Online-Ressource (4 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Timosaponin B-II (TB-II; (25S)-26-(β-D-glucopyranosyloxy)-3β-[(2-O-β-D-glucopyranosyl-β-D-galactopyranosyl) oxy]-5β-furostan-22-ol is extracted from Anemarrhena. Its anti-inflammation, anti-oxidation, and anti-asthma properties have been widely explored. However, its effect on the heart has not been reported. In this study, we used zebrafish as a research model to determine the effects of TB-II on the heart and its toxic and anti-inflammatory effects. To explore the cause of cardioprotective effects of TB-II, we used transgenic zebrafish with macrophages and neutrophils labeled with fluorescent protein. We found for the first time that TB-II had a protective effect on the zebrafish heart. It did not affect the survival and hatching rates of zebrafish embryos, indicating its low toxicity. Results showed that TB-II may have cardioprotective effects, which might be related to its anti-inflammatory effects | ||
700 | 1 | |a Yu, Chu-Qin |e verfasserin |4 aut | |
700 | 1 | |a Du, Meng-Jiao |e verfasserin |4 aut | |
700 | 1 | |a Chen, Jian-Ping |e verfasserin |4 aut | |
700 | 1 | |a Lian, Bo-Wen |e verfasserin |4 aut | |
700 | 1 | |a Mei, Wen-Jie |e verfasserin |4 aut | |
700 | 1 | |a Yu, Jia-Xian |e verfasserin |4 aut | |
700 | 1 | |a Chen, Li-Shi |e verfasserin |4 aut | |
700 | 1 | |a Deng, Shan-Bin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Die Pharmazie <Eschborn> |d Eschborn : Avoxa, Mediengruppe Deutscher Apotheker, 1995 |g 75(2020), 5, Seite 200-203 |h Online-Ressource |w (DE-627)KFL000005991 |w (DE-600)2026715-0 |w (DE-576)110736133 |7 nnns |
773 | 1 | 8 | |g volume:75 |g year:2020 |g number:5 |g pages:200-203 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/doi.org/10.1691/ph.2020.9869 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_EACS_02 | ||
951 | |a AR | ||
952 | |d 75 |j 2020 |e 5 |h 200-203 |